Your basket has

no items

What Should You Do?

The Newly Approved Drug

A new drug has recently been approved by the FDA. Two drugs within the same class have been withdrawn from the market due to safety issues, while one other drug in the class remains on the market. What should you do?
Immediately place the drug in stock.
Wait 6 months to stock the drug, to make sure it has no serious unknown risks.
Verbally counsel patients about the unknown risks of the new drug.
Require written informed consent of patients for the first 6 months.
Home page    /    Products    /    Study Guides

Pharmacy Law Self Study Guides

Pharmacy Law Self Study Guides - COMPREHENSIVE VERSION
Comprehensive State-by-State guides plus practice questions for the study of federal and state laws necessary as preparation for each state's pharmacy licensure exam.
Preview the Index of The State and Federal Pharmacy Law Study Guide
Click on any of the states below to download the corresponding guide...
our price $ 99.95 ea. (RECOMMENDED)
  • Arizona (356 pages) updated as of 4/28/11
  • Connecticut (304 pages) updated as of 4/28/11
  • Florida (299 pages) updated as of 12/31/10
  • Georgia (364 pages) updated as of 2/1/11
  • Illinois (267 pages) updated as of 2/1/11
  • Maryland (303 pages) updated as of 4/28/11
  • Massachusetts (305 pages) updated as of 4/28/11
  • Michigan (291 pages) updated as of 2/1/11
Pharmacy Law Self Study Guides - 4 PAGE CONDENSED VERSION
Condensed 4-page State-by-State guides to initiate the study of federal and state laws necessary as preparation for each state's pharmacy licensure exam. Click on any of the states below to download the corresponding guide...
our price $ 9.95 ea.
PLEASE NOTE: ALL STUDY GUIDES ARE DOWNLOADED TO YOUR COMPUTER ELECTRONICALLY AT THE TIME OF YOUR PURCHASE. PLEASE FOLLOW THE INSTRUCTIONS PROVIDED. RXLAW DOES NOT PROVIDE PRINTED VERSIONS OF THE STUDY GUIDES.
Copyright © 2012 RxLaw.org. All rights reserved.
*NAPLEX and MPJE are federally registered trademarks owned by
the National Association of Boards of Pharmacy (NABP) and the pharmacy law review
materials advertised by RxLaw.org herein are in no way authorized or sponsored by NABP.
Terms and Conditions   |   Privacy Policy